4
Changes in Ownership
4D Molecular Therapeutics, Inc. Filed Acc 0001193125-25-251874
Chief Legal Officer sold 2,678 shares at $12.00 ($32,136)
- Chief Legal Officer acquired 1,084 shares (option exercise)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
Bizily Scott · Chief Legal Officer
Table I: Non-derivative
2 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2025-10-24 | Exercise or conversion : show line 1 in the form 10b5-1 | +1,084 | $6.49 | $7,035 | 6,272 | D |
| 2025-10-24 | Sale : show line 2 in the form 10b5-1 | −2,678 | $12.00 | $32,136 | 3,594 | D |
| Open-market sales · 2,678 sh · avg $12.00 · $32,136 | ||||||
Table II: Derivative
1 line| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2025-10-24 | Exercise or conversion : show line 3 in the form 10b5-1 Stock Option (Right to Buy) | −1,084 | 9,295 | D |
Loading xslF345X05/ownership.xml…